Neutropenia – Asian Scientist Magazine

neutropenia

Pharma

South Korean FDA Approval For Green Cross’ Neulapeg®

Green Cross receives regulatory approval for its once-per-cycle dose neutropenia drug, Neulapeg®.

Pharma

Mode Of Action Of Plerixafor Unraveled

Scientists have discovered the exact mode of action by plerixafor, a drug commonly prescribed to stimulate immune responses in patients suffering from neutropenia.

EDITOR’S PICK

10 Years Of Celebrating Asia’s Researchers

Every year, Asian Scientist Magazine publishes Asian Scientist 100, a carefully curated list of the best and brightest researchers and leaders in SETM in Asia. This year we complete a decade of doing so.
Learning From Environmental Defenders

Drawing on traditional knowledge systems, environmental researchers and policymakers in Asia are working with indigenous communities to design better strategies for environmental conservation.
The Equalizers

Across Asia, people with disabilities are breaking physical and social barriers to STEM fields, opening the way for others.

South Korean FDA Approval For Green Cross’ Neulapeg®

Mode Of Action Of Plerixafor Unraveled

EDITOR’S PICK

10 Years Of Celebrating Asia’s Researchers

Learning From Environmental Defenders

The Equalizers